Hypertension in end-stage renal disease: different measures and their prognostic significance

Walter H Hörl1

  • 1Division of Nephrology and Dialysis, Department of Medicine III, University of Vienna, Vienna, Austria. Walter.hoerl@meduniwien.ac.at

Insights

Maintaining normal fluid balance (normovolaemia) is crucial for managing high blood pressure (hypertension) in haemodialysis patients. Strict volume control through methods like ultrafiltration and salt restriction can reduce or eliminate the need for blood pressure medications.

Area of Science:

  • Nephrology
  • Cardiology
  • Internal Medicine

Background:

  • Hypertension is a significant risk factor for cardiovascular morbidity and mortality.
  • The majority of haemodialysis (HD) patients experience hypertension.
  • Accurate blood pressure (BP) assessment and target levels in HD patients lack sufficient prospective data.

Purpose of the Study:

  • To emphasize normovolaemia as the primary therapeutic target in haemodialysis patients.
  • To discuss non-pharmacological strategies for managing hypertension in HD patients.
  • To highlight the need for further research on optimal BP targets and treatments.

Main Methods:

  • Focus on achieving normovolaemia through dry-weight reduction via additional ultrafiltration.
  • Implementing daily dietary salt restriction or individually lowered dialysate sodium.
  • Considering alternative HD modalities like long, slow home HD, frequent short HD, or nocturnal HD.

Main Results:

  • Strict volume control can significantly reduce or eliminate the need for antihypertensive drug treatment.
  • Alternative HD modalities have shown potential in reducing BP and left ventricular hypertrophy.
  • Prospective data is limited, necessitating further investigation.

Conclusions:

  • Normovolaemia is the key therapeutic target for managing hypertension in haemodialysis patients.
  • Non-pharmacological interventions, particularly strict volume control, are effective.
  • Further research is required to establish optimal BP targets and therapeutic strategies.

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...